SCHEMBL26366263

SCHEMBL26366263

CC(C)CCNC(=O)CCOCCOCCOCCOCCC(C)C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.50
LMNA P02545 2/20 0.45
PKM P14618 1/20 0.45
ALDH1A1 P00352 2/20 0.44
CNR1 P21554 2/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 3/20 0.40
NAMPT P43490 2/20 0.40
POLB P06746 1/20 0.40
CNR2 P34972 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 1/20 0.38
ANPEP P15144 3/20 0.38
RNPEP Q9H4A4 2/20 0.38
DNPEP Q9ULA0 2/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24356349 1.00 HPGD (0.50) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL25836805 1.00 HPGD (0.50) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL25974537 1.00 HPGD (0.50) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL26031870 0.93 MEN1 (0.50) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL23334288 0.93 MEN1 (0.50) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL25834766 0.93 MEN1 (0.50) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL25834703 0.91 MEN1 (0.47) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL17874808 0.91 MEN1 (0.47) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL24530494 0.90 HPGD (0.48) HPGDLMNAPKMALDH1A1CNR1
SCHEMBL21311727 0.88 TSHR (0.46) HPGDLMNAPKMALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295097-A1 LIPIDIC COMPOUNDS COMPRISING AT LEAST ONE TERMINAL RADICAL OF FORMULA -NH-CX-A OR -NH-CX-NH-A, COMPOSITIONS CONTAINING THEM AND USES THEREOF SANOFI PASTEUR (FR) 2023-09-21 US disclosed
US-20230295097-A1 LIPIDIC COMPOUNDS COMPRISING AT LEAST ONE TERMINAL RADICAL OF FORMULA -NH-CX-A OR -NH-CX-NH-A, COMPOSITIONS CONTAINING THEM AND USES THEREOF SANOFI PASTEUR (FR) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295097-A1 LIPIDIC COMPOUNDS COMPRISING AT LEAST ONE TERMINAL RADICAL OF FORMULA -NH-CX-A OR -NH-CX-NH-A, COMPOSITIONS CONTAINING THEM AND USES THEREOF PRDX5, ANXA5, PRDX1 HPGD 587/4885LMNA 101/4885PKM 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.